Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Feb;44(2):226-30.
doi: 10.1136/gut.44.2.226.

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

A Attar  1 , M Lémann, A Ferguson, M Halphen, M C Boutron, B Flourié, E Alix, M Salmeron, F Guillemot, S Chaussade, A M Ménard, J Moreau, G Naudin, M Barthet
Affiliations
Clinical Trial

Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation

A Attar et al. Gut. 1999 Feb.

Abstract

Background: Polyethylene glycol (PEG) 3350 is a non-absorbable, non-metabolised osmotic agent used in lavage solutions for gut cleansing.

Aims: To compare the efficacy of PEG and lactulose in chronic constipation.

Methods: A total of 115 patients with chronic constipation entered a multicentre, randomised, comparative trial. They initially received two sachets containing either PEG (13 g/sachet) or lactulose (10 g/sachet) and were given an option to change the dose to one or three sachets/day, depending on response.

Results: Ninety nine patients completed the trial. After four weeks, patients in the PEG group (n=50) had a higher number of stools and a lower median daily score for straining at stool than patients in the lactulose group (n=49). Overall improvement was greater in the PEG group. Clinical tolerance was similar in the two groups, but flatus was less frequently reported in the PEG group. The mean number of liquid stools was higher in the PEG group but the difference was significant only for the first two weeks. There were no serious adverse events and no significant change in laboratory tests in either group. At the end of the study, the number of sachets used by the patients was 1.6 (0.7)/day in the PEG group and 2.1 (0.7)/day in the lactulose group. Sixty one patients completed a further two months open study of one to three sachets PEG daily; there was no loss of efficacy and no serious toxicity.

Conclusion: Low dose PEG 3350 was more effective than lactulose and better tolerated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical tolerance of PEG (black bars) and lactulose (white bars). The percentage of patients with a median daily score greater than 1 was significantly lower in the PEG group for bloating (p<0.05) and a trend was found for abdominal pain, flatus, and rumbling.
Figure 2
Figure 2
Percentage of patients taking the different dosages of PEG (black bars) and lactulose (white bars) during the last two weeks of the study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Am Pharm Assoc Am Pharm Assoc. 1955 Jan;44(1):27-30 - PubMed
    1. Am J Med. 1990 Nov;89(5):597-601 - PubMed
    1. Am J Gastroenterol. 1990 Mar;85(3):261-5 - PubMed
    1. J Clin Invest. 1989 Oct;84(4):1056-62 - PubMed
    1. J Am Geriatr Soc. 1978 May;26(5):236-9 - PubMed